ArticleGenes & cancer2024

Mechanistically based blood proteomic markers in the TGF-β pathway stratify risk of hepatocellular cancer in patients with cirrhosis.

Xiyan Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.